Global Ganja Report

Oakland-based cannabis industry research firm ArcView Group has released a new study, ambitiously entitled "The Road Map to a $57 Billion Worldwide Market." It provides a sweeping overview of recent progress and future prospects for legal or medical herb across the globe. But it also warns that, due to continued legal restrictions and bureaucratic overstretch, the market is in most areas bottlenecked from achieving its potential.

A United Nations study brings back the surprise finding that the world's biggest producer of legal cannabis is Great Britain. The answer to this seeming anomaly lies in one UK-based multinational corporation with industrial-scale grow operations for production of pharmaceuticals.

Panama may be the next Latin American country to pass a medical marijuana law, with the nation's National Assembly now debating a measure. But, in sharp contrast to that in neighboring Colombia, the Panamanian program would fly pretty close to the ground. In a play to social conservatives, the law would only allow imports, and users would be limited to extracts rather than herbaceous cannabis. And even this may face a fight from opposition lawmakers.

The process of working out implementing regulations for Peru's new medical marijuana program is now officially in extra innings, extending beyond the 60-day window that opened with the signing of the law in November. Advocates are still watching to see whether homegrown will be permitted or just lab-grown, and what constitutes a "laboratory." Meanwhile, despite this tentative progress, the cannabis-growing heartland of the Norte Chico continues to see big militarized police raids on campesino cultivation.

A judge for the US District Court for the Southern District of New York on Feb. 26 dismissed a lawsuit challenging the Schedule I classification for cannabis under the Controlled Substances Act. Judge Alvin Hellerstein granted the government's motion to dismiss because the plaintiffs failed to exhaust all administrative remedies prior to initiating the suit. The "exhaustion rule" requires "that parties exhaust prescribed administrative remedies before seeking relief from federal courts."

A recent court decision regarding a seemingly prosaic controversy over the zoning of medical marijuana businesses in Detroit actually sheds light on issues of what some activists are calling "cannabis equity"—how questions of social and racial justice related to the war on drugs will be addressed as the industry is day-lighted.

Just little over a week before legalization took effect in California on Jan. 1, state police stopped a truck hauling 1,875 pounds of cannabis in Mendocino County, seizing the goods and slapping the two occupants with misdemeanor possession charges. This despite the fact that they were hauling for their employer, Ukiah-based Old Kai Logistics, and had paperwork showing the firm is licensed by county authorities. It remains to be seen if prosecutors will pursue the case in light of legalization, and the affair has enflamed suspicions between growers and authorities at a critical moment.

Longtime California cannabis crusader Dennis Peron, who probably did more than any other one human being to bring about legalization of medical marijuana, died Jan. 27 at a San Francisco veteran's hospital, following a battle with lung cancer. He was 72. Peron was the prime mover behind San Francisco's Proposition P, the 1991 voter initiative that made the city the first government entity in the US to officially embrace medical marijuana, deprioritizing police enforcement for medicinal users.